Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.

AI/ML

Health Care

Nucleai

Nucleai's headquarters in Tel Aviv, Israel

Avi Veidman

Elad Amsalem

Lotan Chorev

Byron Lawson

Dudi Benayoun

Golan Mizrahi

Julian Adams

Hossein Borghaei

Alexander J. Lazar

Yuval Dimnik

Tom Gibbs

Andrew Harrison

Michael Pellini

Ester Abels

Anna Pokorska-Bocci

Suzana Cuoto

Cris De Luca

Noga Yerushalmi

Renana Ashkenazi

Emanuel Timor

The Medical Data Team at Nucleai specializes in curating, analyzing, and interpreting complex medical and tissue data. By leveraging Nucleai’s AI-powered platform, they provide crucial insights that drive biomarker discovery projects and enhance drug development for improved patient outcomes.

Medical Data Team

The Data Science Team at Nucleai is responsible for developing and implementing advanced machine learning and deep learning algorithms to analyze unique tissue datasets. They collaborate closely with medical data specialists to extract meaningful insights into cancer biology, enhancing drug development processes and clinical trial efficacy. The team plays a crucial role in biomarker discovery projects, ultimately aiming to improve patient outcomes through data-driven research and innovation.

Data Science Team

The Directors team at Nucleai oversees strategic initiatives across various domains such as biomedical research, engineering, marketing, and data operations. They ensure the seamless integration of Nucleai's AI-powered platform into drug development processes, while fostering collaborations with pharmaceutical partners and driving biomarker discovery projects to enhance clinical trial efficacy and improve patient care.

Directors

The Leadership Team at Nucleai is responsible for setting the strategic direction, fostering innovation, and steering the company towards its goals. This team, comprising key executives like the CEO, CTO, and Chief Product Officer, collaborates to ensure the seamless integration of Nucleai's AI-powered platform in drug development. They also drive business growth through partnerships, product advancements, and financial management, while strengthening relationships with pharmaceutical companies and enhancing patient outcomes through strategic initiatives.

Leadership Team

The Advisors and Observers team at Nucleai provides strategic guidance and critical insights to enhance the company's AI-powered spatial biology platform. Advisors bring their expertise to inform decision-making and guide clinical trial strategies, while Observers offer impartial, data-driven insights to ensure objective evaluation of research outcomes and collaborations. Together, they help maximize the impact of Nucleai’s platform on drug development and patient care.

Advisors and Observers

The Business Development and Strategy Team at Nucleai is responsible for identifying and establishing partnerships with leading pharmaceutical companies, driving commercial strategy and operations, and negotiating business agreements. This team focuses on expanding the company’s market presence, developing strategic initiatives to advance Nucleai's AI-powered platform adoption, and supporting biomarker discovery collaborations to ultimately improve drug development and patient outcomes.

Nucleai

Org chart

Board & advisors

Teams

Medical Data Team

Data Science Team

Directors

Leadership Team

Advisors and Observers

Business Development and Strategy Team

Offices

Nucleai

Org chart

Board & advisors

Teams

Medical Data Team

Data Science Team

Directors

Leadership Team

Advisors and Observers

Business Development and Strategy Team

Offices

Related companies